[1]
Ivanov, D. 2021. Safety and effectiveness of rheosorbilact detoxification therapy in stage 1–3 CKD. KIDNEYS. 10, 2 (Sep. 2021), 65–69. DOI:https://doi.org/10.22141/2307-1257.10.2.2021.234321.